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ABSTRACT 
Objective: Visceral leishmaniasis is a neglected tropical disease resulting in death if not properly treated. The ongoing search for better 
leishmanicidal compounds has brought herbal drugs into the limelight as safe and effective substitutes to conventional therapies which have 
various drawbacks. The current study was designed to evaluate the antileishmanial efficacy of medicinal plant Chenopodium album Linn. against 
Leishmania donovani in inbred BALB/c mice.  
Methods: Inbred BALB/c mice were infected intravenously with 1x107
Results: The animals treated with methanolic extracts of C. album, revealed a significant reduction in parasite load. These animals also showed 
heightened delayed type hypersensitivity (DTH) response and increased IgG2a as an indicator of protective Th1 type of immune response. 
Moreover, the liver and kidney function tests were found to be in the normal range.  
 Leishmania donovani promastigotes and kept for 30 d. These animals were 
then treated with two doses (500 mg/kg body wt. and 1000 mg/kg body wt.) of methanolic extracts of C. album orally for 7 d. 
Conclusion: Hence the drug proved to be a good antileishmanial, but further studies recommended before it is to be tested in higher animal models.  
Keywords: Visceral leishmaniasis, Chenopodium, BALB/c, DTH 
© 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 
 
INTRODUCTION 
Visceral Leishmaniasis (VL; Kala-azar) is a vector-borne disease 
caused by protozoan parasite Leishmania donovani. It is a life-
threatening infectious disease affecting around 500,000 and killing 
50,000 individuals a year [1]. 90% of the cases are concentrated in 
the parts of India, Brazil, Sudan, Nepal, Ethiopia and Bangladesh. The 
disease is characterized by fever, pallor, hepatosplenomegaly, 
lymphadenopathy, immunosuppression and progressive weakness 
in the patient. It may lead to death if untreated [2]. A large number 
of drugs are available to treat the disease, but unfortunately, 
available drugs for the treatment have been shown to have toxic 
effects, which besides their efficacy reduction due to the emergence 
of parasite-resistant strains [3], urges the development of new 
therapeutic agents capable of controlling this disease [4,5]. 
Moreover till date, there is no commercial vaccine against any 
human parasitic disease including leishmaniasis. The absence of an 
antileishmanial vaccine and an ideal and cheap drug to reverse the 
immunosuppression poses a major challenge for VL elimination in 
the Indian subcontinent and worldwide [6]. 
Therefore, in the sparse inventory of antileishmanial drugs and the 
emergence of resistance, it is high time to implement strategies 
which could overcome drug unresponsiveness. An immuno-
modulatory drug with anti-leishmanial functions which not only kills 
the parasite but also promotes the host protective immune response 
is necessary for the treatment of this dreaded disease [4, 5]. A search 
is on for new drugs that are less toxic, easily available and within the 
reach of poor people most afflicted by the disease [7]. In this sense, 
traditional medicine is gaining particular importance nowadays [4, 5]. 
Numerous plant derived products from different structural classes 
have been investigated as antileishmanial candidates including various 
alkaloids, terpenoids, flavonoids and quinonoid [8]. 
The genus Chenopodium Linn. (family-Chenopodiaceae) is a native 
plant of Western Asia. In India, the plant is well known for its 21 
species some of which are also used as a source of food and grains. C 
album Linn. is commonly used for food and medicinal values; viz 
bathu sag, parupkkirai etc and grows in waste places and as a weed 
in wheat or other crops [9]. The plant is widely neglected herb with 
various pharmacological properties like antiviral, antimalarial, 
immunomodulatory, anti-allergic etc [10, 11]. It has been found to 
have flavonoids as phenolic amide, saponin, cinnamic acid amide, 
xyloside, phenols and lignin, etc. [12-15]. Essential oils extracted from 
C. ambrosioides (alpha-terpinene, p-cymene, and ascaridole) exhibited 
similar antileishmanial activities against intracellular amastigote form, 
with IC50 values between 4.7 and 12.4 µg/ml [16]. The methanolic 
extract of C album has been shown to have anticancerous activity and 
positive results have been obtained with the successful control of the 
growth of cells [17]. Alcoholic and aqueous extracts of C album have 
been reported to restore the integrity of hepatocytes significantly and 
reversed the integrity of alcohol induced side effects [18]. These findings 
demonstrated that C album has immense potential as a medicinal plant. 
Thus, with an urge to find a safe, natural and cheap antileishmanial drug 
that is not toxic and can cause a reversal of immunosuppression, the 
present study has been designed to evaluate the antileishmanial activity 
of Chenopodium album in inbred BALB/c mice against visceral 
leishmaniasis. 
MATERIALS AND METHODS 
Parasite 
The strain of parasite used for the present study was MHOM/ 
IN/80/Dd8 originally obtained from London School of Tropical 
Hygiene and Medicine, U. K. The promastigotes of these strains were 
maintained in RPMI-1640 medium with 10% fetal calf serum (FCS). 
Plant material 
Chenopodium album as the whole plant was collected from roadside 
near Dhanas lake, Chandigarh, India. The identification was 
confirmed from the Department of Botany, Panjab University, 
Chandigarh, India and number were taken (voucher number: 1445). 
Whole plants of C. album were washed thoroughly with water and 
dried at room temperature and then powdered. 
Preparation of the extracts 
In the present study, leaves and fruits of Chenopodium album were 
used for extraction. They were washed thoroughly with distilled 
water, dried at room temperature for few days and then ground 
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using a blender. The methanolic extract of the leaves and fruits was 
prepared by Soxhlet extraction method. The crude extract was obtained 
after filtration with Whatman's filter paper and evaporated under low 
pressure in a rotary evaporator. The sample was then lyophilized and 
the condensed extract stored at 4 ˚C for further studies. 
Preparation of the standard drug 
Sodium stibogluconate (SSG) was purchased from Sigma-Aldrich Co., 
USA and required concentration of 40 mg/kg b. wt was prepared by 
dissolving it in distilled water at 72ºC in water bath [19]. 
In vivo antileishmanial activity of plant extract 
Animals 
Inbred BALB/c mice (5-6 w old) were purchased from the Institute 
of Microbial Technology and maintained at Central Animal House of 
Panjab University, Chandigarh. Animals were allowed to acclimatize 
to the laboratory conditions for at least 2 w before experimental 
manipulation. All mice were maintained on a 12-hour light/dark 
cycle with free access to water and food ad libitum and were housed 
6 mice per cage. The permission for conducting experiments was 
obtained from Institutional Animal Ethics Committee of Panjab 
University, Chandigarh (Approval no-IAEC/284-295). 
Infection and treatment of animals 
The animals were infected with 1 x 107
Groups of animals 
 promastigotes of L. donovani 
intravenously. After 30 d post infection, mice were treated with two 
different doses (500 mg/kg body wt and 1000 mg/kg body wt.) of C 
album for 7 d orally. These drugs were prepared by dissolving in 
standard suspension vehicle (SSV). SSV was prepared by mixing 
carboxymethyl cellulose (5g), benzyl alcohol (5 ml) and tween-80 (4 ml) 
in 0.9% aqueous sodium chloride (1000 ml). Mice receiving Phosphate-
buffered saline (PBS) only served as normal controls. Infected untreated 
mice were considered as infected controls, and the treated controls 
consisted of uninfected mice receiving either of the two doses (500 mg 
or 1000 mg/kg body weight) of the plant extract. SSG was given 
intraperitoneally at a dose of 40 mg/kg body wt. for 5 d continuously.  
All animals were divided into seven groups. Each group contained 
12 mice and six mice in each group were sacrificed on 1 and 15 d 
post treatment. 
Group I: Normal mice 
Group II: Infected mice 
Group III: Infected mice treated with SSG  
Group IV: Normal mice treated with Chenopodium album (500 
mg/kg body wt.) 
Group V: Infected mice treated with Chenopodium album (500 
mg/kg body wt.) 
Group VI: Normal mice treated with Chenopodium album (1000 
mg/kg body wt.) 
Group VII: Infected mice treated with Chenopodium album (1000 
mg/kg body wt.) 
Assessment of infection:  
Six mice from each group were sacrificed on 1 and 15 d. p. t. (days 
post treatment). Impression smears of liver were made on clean, 
grease free slides, fixed in methanol and stained with giemsa. The 
parasite load was calculated in the form of Leishman-Donovan Units 




X Weight of organ (mg) 
Delayed-type hypersensitivity (DTH) responses 
The mice were given a subcutaneous injection of leishmanin in the 
right footpad and PBS (control) in the left footpad. The leishmanin 
was prepared by according to the method of Joshi et al., [21]. 
Humoral immune response 
The levels of IgG1 and IgG2a antibodies were measured by indirect 
ELISA in serum samples of different groups of animals [19]. 
Evaluation of biochemical parameters 
Liver function tests 
Serum Glutamate Oxaloacetate Transaminase (SGOT), Serum 
Glutamate Pyruvate Transaminase (SGPT), Alkaline liver 
phosphatase (ALP) and bilirubin were tested by using commercially 
available kits (Reckon Diagnostics Pvt. Ltd. Vadodra, India) [21]. 
Kidney function tests 
Urea and creatinine were estimated by using commercially available 
kits (Reckon Diagnostics Pvt. Ltd. Vadodra, India). 
Statistical analysis 
The student’s t-test was performed to calculate the p-value for 
significance; p-values<0.05 were considered significant. Results 
were expressed as mean±standard deviation (SD) of three 
independent experiments.  
RESULTS 
Hepatic parasite load 
The parasite load was measured in terms of LDU. In the case of the 
infected animals treated with C. album, the parasite load was 
significantly (p<0.05) lowered as compared to the infected 
animals. 
However, the reduction in parasite load was more in animals treated 
with 1000 mg/kg body wt. of C. album (1220.05±55.70 and 1160. 
89±47.61) as compared to 500 mg/kg body wt (1101.90±40.27 and 
990.78±33.45) of C. album on 1 and 15 d. p. t. respectively (fig. 1). 
The LDU in the infected animals treated with SSG at a dose of 40 
mg/kg body wt. was found to be 687.21±27.21and 501.76±15.98 on 
1 and 15 d. p. t. respectively. 
 
 
Fig. 1: Parasite load in various groups of BALB/c mice 
*p-value: Infected vs all the groups p<0.05, Results were expressed 
as mean±SD of three independent experiments 
 
Delayed-type hypersensitivity responses 
In the infected animals treated with C album at a dose of 500 
mg/kg body wt, DTH was found to be 36.67±1.89 and 41.87±1.85 
on 1 and 15 d. p. t. respectively. These responses augmented 
with an increase in the dose of the drug and post treatment days 
(p<0.05) i.e. 38.45±1.26 and 42.54±1.76 on 1 and 15 d. p. t in 
infected and treated animals with 1000 mg/kg body wt. of C 
album (fig. 2). The DTH responses were greater in infected 
animals treated with SSG as compared to the animals treated 
with C album.  
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Fig. 2: DTH responses in various groups of BALB/c mice 
*p-value: Infected vs all the groups p<0.05, Results were expressed 
as mean±SD of three independent experiments 
 
Humoral immune responses 
Antibody responses in different groups of animals were analyzed for 
isotype specific IgG1 and IgG2a antibodies in the sera of animals. 
Treated animals reveal greater IgG2a (p<0.05) and lesser IgG1 levels 
in comparison to the infected controls (p<0.05). Maximum IgG2a 
levels were observed in the animals treated with C album at a higher 
dose pointing towards the generation of the protective Th1 immune 
responses (fig. 3 and fig. 4).  
 
 
Fig. 3: IgG1 antibody levels in various groups of BALB/c mice 
*p-value: Infected vs all the groups p<0.05, Results were expressed 
as mean±SD of three independent experiments 
 
 
Fig. 4: IgG2a antibody levels in various groups of BALB/c mice 
*p-value: Infected vs all the groups p<0.05, Results were expressed 
as mean±SD of three independent experiments 
Biochemical parameters 
Liver function tests 
The levels of SGOT, SGPT, ALP and bilirubin were estimated in the 
serum samples of all the groups of mice. The concentration of all 
these enzymes were higher in the infected animals as compared to 
all the other groups (p<0.05) in which normal levels of these liver 
function tests were observed. The infected animals treated with SSG 
revealed the elevated levels of SGOT and SGPT in the serum samples 
(fig. 5, fig. 6, fig. 7 and fig. 8).  
 
Fig. 5: SGOT activity in various groups of BALB/c mice on 
different days post treatment 
*p-value: Infected vs all the groups p<0.05, Results were expressed 
as mean±SD of three independent experiments 
 
 
Fig. 6: SGPT activity in various groups of BALB/c mice on 
different days post treatment 
*p-value: Infected vs all the groups p<0.05, Results were expressed 
as mean±SD of three independent experiments. 
 
 
Fig. 7: Alkaline Liver Phosphatase (ALP) activity in various 
groups of BALB/c mice on different days post treatment 
*p-value: Infected vs all the groups p<0.05, Results were expressed 
as mean±SD of three independent experiments 
* 
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Fig. 8: Bilirubin concentration in various groups of BALB/c mice 
on different days post treatment 
*p-value: Infected vs all the groups p<0.05, Results were expressed 
as mean±SD of three independent experiments 
 
Kidney function tests 
Kidney function tests include estimation of urea and creatinine. The 
concentration of serum creatinine and blood urea was observed to 




Fig. 9: Creatinine concentration in various groups of BALB/c 
mice on different days post treatment 
*p-value: Infected vs all the groups p<0.05, Results were expressed 
as mean±SD of three independent experiments 
 
 
Fig. 10: Urea concentration in various groups of BALB/c mice on 
different days post treatment 
*p-value: Infected vs all the groups p<0.05, Results were expressed 
as mean±SD of three independent experiments 
Though the levels of creatinine in the animals treated with SSG were 
in the normal range, they were higher as compared to the normal 
animals and to the animals treated with the herbal extracts, 
indicating that SSG is nephrotoxic at higher concentration. Blood 
urea and creatinine levels were found to be in the normal range in 
the animals treated with C album on all days post treatment (fig. 9 
and fig. 10). 
DISCUSSION  
Despite the wealth of information regarding the genetics of the 
parasite and experimental immunology of the disease, there is 
currently no licensed vaccine against Leishmania and control 
measures rely on chemotherapy to alleviate the disease and on 
vector control to reduce the transmission [22]. Most of the drugs 
employed for treatment are toxic, marginally effective, given by 
injection or compromised by the development of resistance. Since 
safe, effective and affordable chemotherapeutic agents for 
leishmaniasis are clearly needed, the identification of new 
antileishmanial candidates is an urgent priority. 
Therefore in view of the present clinical scenario, it is desirable that 
new drugs should be developed with lesser cost, lower toxicity, and 
more effectiveness. Thus, the present study was carried out to 
evaluate the leishmanicidal properties of Chenopodium album in 
inbred BALB/c mice against visceral leishmaniasis.  
Resistance to Leishmania infection depends on intracellular parasite 
killing by activated macrophages through the production of 
activated nitric oxide (NO) pathways. In our present study, the 
parasite count was observed minimum in treated animals as 
compared to the infected animals. However, maximum reduction 
was seen in animals given a higher dose of crude extracts (1000 
mg/kg body wt.) as compared to the lower dose of the crude extract 
of C. album. Our results are in synchrony with the studies conducted 
by Makwali et al., [23] using a single dose of saponin, plumbagin, 
trifluralin and acriflavine resulted in 97.8%, 98.8%, 86.4% and 
85.4% reductions in liver amastigotes burden on day 7 post-
treatment respectively. In a similar study, Tinospora sinensis reduced 
the parasite load by 76.2±9.2% by enhancing reactive oxygen 
species (ROS) and NO production along with the activation of 
macrophages [24]. In our study, although the reduction in parasite 
load in animals treated with C. album was lesser than those treated 
with SSG, the other medicinal properties of this plant and also the 
fact that it could be administered orally gives an added advantage, 
and thus this drug can be considered as an alternative drug. 
A complex balance between the parasite and the genetic/ 
immunological background of the host are decisive for infection 
evolution and clinical outcome. Delayed-type hypersensitivity is an 
immunologic response that has frequently been used as a 
correlation for protection against or sensitization to Leishmania 
antigens in human and experimental models of Leishmania infection 
[25]. Chemotherapeutic cure of leishmaniasis is largely dependent 
upon the development of an effective immune response that 
activates macrophages to produce toxic nitrogen and oxygen 
intermediates to kill the amastigotes. In the present study, DTH 
response to leishmanin after treatment with C. album was evaluated 
by the percentage increase in thickness of food. Our results 
demonstrated that treated animals with a higher dose revealed 
increased DTH responses in comparison to the infected controls 
pointing towards the efficacy of this drug in generating an effective T 
cell-mediated immune response.  
In the mouse, it has been shown that antibodies of the IgG1 isotype 
are produced mainly during a Th2 immune response, and IgG2a 
antibodies are produced mainly during Th1 immune responses [26]. 
In the present study, ELISA showed higher levels of protective IgG2a 
antibodies and lower levels of disease progressive IgG1 antibodies in 
the infected animals treated with an extract of C album. IgG2a is a 
Th2 supported subclass characterized by an early IFN-γ production 
and inducible NO synthase by activated macrophages. In contrast, 
IgG1 supports the protective Th1 type of immune response 
characterized by an early burst of interleukin-4 expression and 
succumbs to progressive visceral infection [27]. Similar results were 
observed in our laboratory, where L donovani infected animals 
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treated with the extracts of Azardirachta indica and Emblica 
officinalis showed higher levels of IgG2a and lower IgG1 levels in 
comparison to the infected controls [28]. 
Kidney function is an indication of the state of kidney and its role in 
renal physiology. The results of kidney tests are important in 
assessing the excretory function of kidneys. In the present study, we 
estimated the creatinine and urea concentration in the serum 
samples of infected as well as treated animals. In all the animals 
treated with C album, normal levels of urea and creatinine were 
observed. This suggests that drug does not cause any toxicity. 
Similarly, liver function tests are helpful screening tool and an 
effective modality to detect hepatic dysfunction. They were 
performed by assessing the levels of liver marker enzymes (SGOT, 
SGPT and ALP) and the concentration of bilirubin in the serum 
samples of mice. The present study revealed the elevated levels of 
hepatic enzymes indicative of liver damage on the administration of 
SSG. However, these levels were found to be in the normal range in 
animals treated with extracts of C album. Thus, the results 
demonstrated a marked hepatoprotective effect of the herbal plant. 
Our results are in corroboration with a study by, Nigam and Prakash 
[18] in which they observed a hepatoprotective potential of C album 
against alcohol-induced liver damage and found that the crude 
aqueous and alcoholic extracts showed restoration of serum 
transaminases, alkaline phosphatases, and bilirubin content and did 
not show any sign of toxicity up to an oral dose of 5g/Kg in mice.  
CONCLUSION 
The primary criteria of searching for new drugs effective in 
leishmaniasis are its efficacy along with relatively no or minimum 
side effects as compared to current therapeutic agents. The present 
study demonstrated that C album at a higher dose of 1000 mg/kg b. 
wt. not only reduced the parasite load but enhanced the DTH 
responses and did not cause any toxicity. Thus, it can be considered 
as a potential hepatoprotective and antileishmanial agent alone, or 
in combination therapy. However, future studies should be planned 
with higher doses and on higher animal models to come to a logical 
conclusion. 
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